Gotham Therapeutics is Drug Discovery in United States that focus on neurodegenerative diseases business. Founded in 2017. They cover business area such as developer, novel therapy, cancer, autoimmune and neurodegenerative disease, a pipeline, small molecule, protein, treatment option, patient, serious disease.
2017
( 7 years old in 2024 )
Neurodegenerative Diseases
-
Alexandria Center of Life Sciences, 430 East, 29th Street
Suite 1435E
New York, NY 10016
United States
Private
developernovel therapycancerautoimmune and neurodegenerative diseasea pipelinesmall moleculeproteintreatment optionpatientserious disease
* We use standard office opening hours in near Gotham Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Gotham Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Gotham Therapeutics business is focusing on Neurodegenerative Diseases.
Gotham Therapeutics headquarter office and corporate office address is located in Alexandria Center of Life Sciences, 430 East, 29th Street Suite 1435E New York, NY 10016 United States.
Gotham Therapeutics was founded in United States.
In 2024, Gotham Therapeutics is currently focus on neurodegenerative diseases sector.
Above is snippet of Google Trends for "neurodegenerative diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Gotham Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
